Distinct bone marrow immunophenotypic features define the splicing factor 3B subunit 1 (SF3B1)‐mutant myelodysplastic syndromes subtype

Splicing factor 3B subunit 1 (SF3B1) mutations define a distinct myelodysplastic syndromes (MDS) patient group with a relatively favourable disease course and high response rates to luspatercept. Few data are available on bone marrow phenotype beyond ring sideroblasts in this subgroup of patients wi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Br J Haematol
Egile Nagusiak: Duetz, Carolien, Westers, Theresia M., in ’t Hout, Florentien E. M., Cremers, Eline M. P., Alhan, Canan, Venniker‐Punt, Bianca, Visser‐Wisselaar, Heleen A., Chitu, Dana A., de Graaf, Aniek O., Smit, Linda, Jansen, Joop H., van de Loosdrecht, Arjan A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2021
Gaiak:
Haematological malignancy ‐ Biology
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8252736/
https://ncbi.nlm.nih.gov/pubmed/33765355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.17414
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak